Cargando…
Luteolin Reduces Alzheimer’s Disease Pathologies Induced by Traumatic Brain Injury
Traumatic brain injury (TBI) occurs in response to an acute insult to the head and is recognized as a major risk factor for Alzheimer’s disease (AD). Indeed, recent studies have suggested a pathological overlap between TBI and AD, with both conditions exhibiting amyloid-beta (Aβ) deposits, tauopathy...
Autores principales: | Sawmiller, Darrell, Li, Song, Shahaduzzaman, Md, Smith, Adam J., Obregon, Demian, Giunta, Brian, Borlongan, Cesar V., Sanberg, Paul R., Tan, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907845/ https://www.ncbi.nlm.nih.gov/pubmed/24413756 http://dx.doi.org/10.3390/ijms15010895 |
Ejemplares similares
-
The immunology of traumatic brain injury: a prime target for Alzheimer’s disease prevention
por: Giunta, Brian, et al.
Publicado: (2012) -
Baicalein reduces β-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer’s disease transgenic mouse model
por: Zhang, She-Qing, et al.
Publicado: (2013) -
Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer’s mice
por: Li, Song, et al.
Publicado: (2015) -
Human Umbilical Cord Blood Serum–derived α-Secretase: Functional Testing in Alzheimer’s Disease Mouse Models
por: Habib, Ahsan, et al.
Publicado: (2018) -
LISPRO mitigates β-amyloid and associated pathologies in Alzheimer’s mice
por: Habib, Ahsan, et al.
Publicado: (2017)